Jerry A Molitor MD
Spondyloarthropathy
Associate Professor, Medicine, University of Minnesota Medical School
Join to View Full Profile
516 Delaware Street SE Clinic 6aUMP Medicine Specialties ClinicMinneapolis, MN 55455
Phone+1 612-884-0649
Dr. Molitor is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of WashingtonFellowship, Rheumatology, 1997 - 1999- University of WashingtonResidency, Internal Medicine, 1994 - 1997
University of Iowa Roy J. and Lucille A. Carver College of MedicineClass of 1993
Certifications & Licensure
MN State Medical License 2007 - 2026
WA State Medical License 1997 - 2008
American Board of Internal Medicine Rheumatology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2012, 2014-2017
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2012, 2014-2017
- Regional Top Doctor Castle Connolly, 2014
Clinical Trials
- A Phase 2 Study to Evaluate the Safety, Tolerability, and Activity of Fontolizumab in Subjects With Active Rheumatoid Arthritis Start of enrollment: 2005 Dec 01
- Multi-center, Web Based Observational Study of Pulmonary Hypertension in Scleroderma Patients Start of enrollment: 2005 Feb 01
- Rituximab for Treatment of Systemic Sclerosis-Associated Pulmonary Arterial Hypertension (SSc-PAH) Start of enrollment: 2011 Jun 24
Publications & Presentations
PubMed
- Type III and type VI collagen neoepitopes are associated with disease severity in systemic sclerosis.Ali Y Ayla, Elana J Bernstein, Meng Zhang, John M VanBuren, Flavia V Castelino
The Journal of Rheumatology. 2025-11-15 - 1 citationsHand Swelling and Other Non-Raynaud Phenomenon Symptoms as the Initial Presentation of Systemic Sclerosis: Prevalence and Clinical Associations in Two US Cohorts.Iqtidar Hanif, Shervin Assassi, Maureen D Mayes, Zsuzsanna H McMahan, Meng Zhang
Arthritis & Rheumatology. 2025-11-01 - Use of Nintedanib for the Treatment of Systemic Sclerosis-associated Interstitial Lung Disease at Expert Scleroderma Centers in the United States.Yiming Luo, Shervin Assassi, Maureen D Mayes, Tracy M Frech, Virginia D Steen
Annals of the American Thoracic Society. 2025-08-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
